Boston Scientific Corp.
(NYSE : BSX)

( )
BSX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 0.99%545.951.0%$723.18m
MDTMedtronic Plc 2.03%90.470.6%$692.05m
DHRDanaher Corp. 0.69%256.930.7%$681.40m
ABTAbbott Laboratories 3.03%109.430.8%$608.35m
ISRGIntuitive Surgical, Inc. 2.53%209.670.8%$454.37m
BSXBoston Scientific Corp. 3.25%38.141.0%$339.98m
ALGNAlign Technology, Inc. 3.04%258.756.4%$321.15m
BDXBecton, Dickinson & Co. 3.41%250.801.0%$275.10m
EWEdwards Lifesciences Corp. 3.90%97.270.4%$268.56m
SYKStryker Corp. 2.34%204.741.3%$264.86m
IDXXIDEXX Laboratories, Inc. 1.65%361.483.8%$242.08m
AAgilent Technologies, Inc. 2.07%121.051.7%$225.19m
BAXBaxter International, Inc. 2.61%66.781.8%$207.19m
SWAVShockwave Medical, Inc. 6.27%197.690.0%$175.43m
DXCMDexCom, Inc. 3.27%77.671.9%$172.64m

Company Profile

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Rhythm and Neuro, Cardiovascular and MedSurg. The Rhythm and Neuro segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The Cardiovascular segment consists of technologies for diagnosing and treating coronary artery disease and other cardiovascular disorders including structural heart conditions. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979, and is headquartered in Marlborough, MA.